Chinese herbal granules for long-lasting insomnia compared with placebo
Tests a Chinese herbal medicine against placebo in adults with chronic insomnia.
Key facts
- Who runs it
- Chinese University of Hong Kong
- Where
- Shatin, Hong KongSee the site
- Trial code
- Registry title
- Chinese Medicine in Treating Insomnia
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 76 people, planned
- Started
- 25 Sept 2025
- Expected to end
- Aug 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Modified Suan ZaoRen Tang-TianWang BuXin Dan
- Placebo
- Record updated
- 27 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with long-term insomnia who have a Yin deficiency internal heat pattern in traditional Chinese medicine. It tests Chinese medicine granules against placebo granules for 6 weeks.
- Age
- 18 to 65 years
- Sex
- All sexes
- Disease stage
- Chronic insomnia under DSM-5 criteria: trouble falling asleep, staying asleep, or waking early, at least 3 nights per week for at least 6 months. It must affect daily life. Insomnia Severity Index (ISI) score of at least 8. Yin deficiency-induced internal heat pattern in traditional Chinese medicine.
- Earlier treatment
- No drug or herbal treatment for insomnia within the past month.
Main reasons for not taking part
- Nervous system disease (such as stroke or Parkinson's Disease), mental disorders such as depression or anxiety, or HADS score 11 or above
- Other sleep disorders such as sleep apnea, restless legs or narcolepsy, or insomnia caused by medicines
- Shift or night shift work
- Severe illness such as heart, liver, kidney or blood disease, diabetes, cancer or stroke-related disease
- Pregnancy or breastfeeding, alcohol or drug abuse, or allergy to Chinese herbal medicines
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Age from 18 to 65 years
- Eligible for the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, criteria for insomnia disorder. The criteria include having difficulties in falling asleep, difficulties in staying asleep, or early morning awakening with clinically significant consequences for daily life for at least 3 nights per week for at least 6 months
- Insomnia Severity Index (ISI) total score of at least 8 indicating insomnia at the clinical level
- Diagnosed to be Yin deficiency-induced internal heat pattern according to traditional Chinese Medicine (TCM) theory
- Able to complete questionnaires and take medications as scheduled; and
- Voluntary written consent
Who cannot take part
- Concomitant pharmacological treatment or herbal medicines for insomnia within the past month
- Known alcohol and / or drug abuse
- Known nervous system disease (eg, stroke, Parkinson's Disease)
- Known mental disorders (eg, depression or anxiety) or HADS score 11 or above in any either item
- Known sleeping related diseases (eg. sleep apnea, nocturnal myoclonus, restless legs, severe nocturnal enuresis or narcolepsy) that may affect the sleeping quality
- Know treatment to comorbid sleep disorders, such as sleep apnea or narcolepsy
- Known severe medical conditions, such as cardiovascular, liver, kidney or hematopoietic system disease, diabetes mellitus, cancers, cerebrovascular diseases
- Known allergic history to any Chinese herbal medicines
- Known pharmacologically induced insomnia
- With symptoms that significantly disturb sleep such as pain, fever, diarrhea, frequent micturition, and cough
- Work on shift or on night shift
- Impaired hematological profile and liver / renal function exceeds the upper limit of the reference value by 2 times
- Diagnosed to be deficiency of spleen according to TCM theory
- Any contraindications for taking Chinese medicines in the opinion of the investigators
- Know pregnant or lactating; and
- Involved in other interventional clinical studies at the same time
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in Hong Kong
- Hong Kong Institute of Integrative MedicineShatin, Hong KongContact: Zhixiu LinTaking people
About the trial
What the trial wants to find out
This is a randomized, double-blinded, placebo-controlled clinical trial. Eligible participants will randomized into either treatment group (CM granules) or placebo group (placebo granules) for 6 weeks, followed by a post-treatment visit at week 9. The primary outcome is the change in Pittsburgh Sleep Quality Index (PSQI) at week 6.
The 2 groups in the trial
- mSZT-TBD granulesTreatment being tested
Modified Suan ZaoRen Tang-TianWang BuXin Dan granules
Treatment: Modified Suan ZaoRen Tang-TianWang BuXin Dan
- Placebo granulesPlacebo, for comparison
Treatment: Placebo
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy and Safety of Modified Suan ZaoRen Tang-TianWang BuXin Dan in the Treatment of Chronic Insomnia: A Randomized, Double-blinded, Placebo-controlled Trial
- Plain-language title
- Chinese herbal granules for long-lasting insomnia compared with placeboGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT06511011, who can take part
- Record updated
- 27 July 2026